Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Parkinson Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Testing effectiveness (Phase 2)Study completedNCT01341431
What this trial is testing

Bee Venom for the Treatment of Parkinson Disease

Who this might be right for
Parkinson Disease
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Testing effectiveness (Phase 2)Study completedNCT04332276
What this trial is testing

Dopaminergic RestauratIon by IntraVEntriculaire Administration

Who this might be right for
Parkinson Disease
University Hospital, Lille 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05109364
What this trial is testing

Terazosin and Parkinson's Disease Extension Study

Who this might be right for
Symptomatic Parkinson DiseaseREM Sleep Behavior DisorderPre-motor Parkinson's Disease
Cedars-Sinai Medical Center 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05669170
What this trial is testing

Methylphenidate for Apathy in Veterans With Parkinson's Disease

Who this might be right for
Parkinson DiseaseApathy
Ralph H. Johnson VA Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00180037
What this trial is testing

Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 132
Not applicableStudy completedNCT05388526
What this trial is testing

Frailty and Cognitive Function in Parkinson's Disease.

Who this might be right for
Parkinson Disease
University of Oviedo 100
Not applicableUnknownNCT02361255
What this trial is testing

Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism

Who this might be right for
Secondary ParkinsonismParkinson's Disease
Corporal Michael J. Crescenz VA Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02539784
What this trial is testing

Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease

Who this might be right for
Parkinson
Assistance Publique - Hôpitaux de Paris 6
Not applicableUnknownNCT02275884
What this trial is testing

Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Technische Universität Dresden 30
Testing effectiveness (Phase 2)Study completedNCT00209508
What this trial is testing

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

Who this might be right for
Parkinson's Disease
Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Post-approval studies (Phase 4)Study completedNCT01168596
What this trial is testing

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Florida 30
Testing effectiveness (Phase 2)Study completedNCT05214287
What this trial is testing

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease

Who this might be right for
Parkinson DiseaseEffect of Drug
Radboud University Medical Center 29
Not applicableStudy completedNCT03301935
What this trial is testing

Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation

Who this might be right for
Wolff-Parkinson-White Syndrome
Karolinska University Hospital 168
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Not applicableStudy completedNCT01360229
What this trial is testing

Acupuncture for Fatigue in Parkinson's Disease

Who this might be right for
Parkinsons Disease
University of Colorado, Denver 94
Load More Results